Effect of pentoxyphilin on reducing erythropoietin needs in peritoneal dialysis patiente with anemia
Not Applicable
- Conditions
- End Stage Renal Disease.End-stage renal disease
- Registration Number
- IRCT201101012417N6
- Lead Sponsor
- Vice Chancellor for Research, Isfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
patient’s satisfaction, hemodialysis for at least 1 month prior to the study, hemoglobin concentration less than 10g/dL in at least 2 episodes, Erythropoietin use more than 12000 units per week, no bleeding over the last month prior to the intervention, no infection resulting admission over the last month prior to the intervention, vitamin C consumption 250mg twice a week
Exclusion criteria: drug intolerance, bleeding during the study period, infection resulting admission
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum hemoglobin level. Timepoint: Baseline, monthly, at the end of the study. Method of measurement: g/dL.;Serum albumin. Timepoint: Baseline, monthly, at the end of the study. Method of measurement: g/dL.;Erythropoietin use. Timepoint: monthly. Method of measurement: International unit.
- Secondary Outcome Measures
Name Time Method Serum Iron level. Timepoint: Baseline, 3rd month, at the end of study. Method of measurement: µg/dL.;Total iron binding capacity. Timepoint: Baseline, 3rd month, at the end of study. Method of measurement: µg/dL.